Live News EQUITY H impact Jun 23, 2026, 09:23 AM UTC

ENTA: AbbVie Gets EU Approval

Enanta Pharmaceuticals' partner AbbVie receives European Commission approval of MAVIRET for people with acute Hepatitis C Virus

ENTA

SQUAWKNEWS Updated Jun 23, 2026, 09:23 AM UTC

ENTA - Enanta Pharmaceuticals' Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus